Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Starts & Stops: Sept. 10-16, 2018

Executive Summary

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made Sept. 10 through Sept. 16, including trial announcements from Medtronic, NovoCure, Gore, LivaNova, and BioSig.

You may also be interested in...



Wall Street Tries To Guess The Impact Of Pandemic On Medtech Revenues

As the pandemic unfolds with an uncertain outcome, US securities analysts that cover publicly traded medtech companies are developing mathematical models to estimate the impact of the COVID-19 pandemic on medtech companies.

Everlywell Launches ‘At Home’ COVID-19 Test Collection Kit

The Texas company is planning to sell 30,000 at-home sample collection kits for COVID-19 testing beginning on 23 March.

Device Week, 18 March 2020 – Canceled Surgeries, New Medtech Alliances

In this episode of our weekly podcast, Medtech Insight managing editor Marion Webb talks with deputy editor Reed Miller about her story on US hospitals canceling elective surgeries to preserve critical resources in response to COVID-19, and hospitals joining forces with medtechs to find rapid technological solutions to keep patients and caregivers healthy.

Topics

UsernamePublicRestriction

Register

MT123286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel